Physicochemical aspects of liposomes encapsulating the hrEGF rP64k conjugate

Authors: Luna YH, Torres PLE, Lorenzo MDCL

Journal: Journal of Infectious Diseases & Travel Medicine. Article type: Short Communication. Published: 2026-09-04. DOI: https://doi.org/10.23880/jidtm-16000200

Abstract

The therapeutic vaccine CIMAvax-EGF® is formulated with the hrEGF-rP64k conjugate and Montanide ISA 51 VG®, an oil based adjuvant associated with granuloma formation. In this work, dehydration–rehydration vesicles (DRVs) composed of DPPC:Cholesterol (1:1) were physiochemically characterized as an alternative antigen delivery system, evaluating the effect of sucrose on vesicle size, encapsulation efficiency, and storage stability.

Keywords: Dehydration, Biodegradable, Proteins, Encapsulation, Immunotherapy

Introduction

The therapeutic vaccine CIMAvax-EGF® is based on the conjugate hrEGF-rP64k formulated with Montanide ISA 51 VG®, a mineral oil adjuvant that induces granulomas at injection sites and is not metabolized. These limitations motivate the exploration of biodegradable antigen delivery systems [1].

Liposomal vesicles represent biocompatible and low- immunogenic nanoparticles capable of storing significant amounts of antigen and are not associated with granuloma formation when composed of natural or synthetic phosphatidylcholine [2]. Among preparation methods, dehydration–rehydration vesicles (DRVs) allow efficient encapsulation of labile macromolecules such as proteins due to their large internal aqueous compartment and high material-to-lipid ratio.

In this study, liposomes composed of dipalmitoylphosphatidylcholine (DPPC) and cholesterol (1:1 molar ratio) were prepared following the dehydration– rehydration methodology originally described by Kirby and Gregoriadis [2]. Proteins were incorporated at 30 µg per 6,4 µmol of total lipids. In selected formulations, sucrose was added before lyophilization at a sugar: phospholipid mass ratio of 3:1, reaching final concentrations of 14 mM or 40 mm

Figure 1: Size Of Liposomal Preparations in the Presence or Absence of Sucrose.

Baseline DRVs (without sucrose) were moderately polydisperse, approximately 1 µm in diameter, and encapsulated around 27% of hrEGF-rP64k as determined by fluorimetry and UMELISA-EGF. These values are consistent with previous encapsulation efficiencies reported for similar systems [3].

The size of the vesicles (Lp) wasdetermined by DLS after rehydration. Empty Lp: control vesicles to which no proteins were added. Data from three replicates of the experiment are shown; the bars correspond to the standard deviation. Different letters indicate significant differences according to Tukey’s test (p0.05).

Storage stability was evaluated after 30 and 60 days at −20 °C in the lyophilized state. Liposomes without sucrose showed a significant increase in size and polydispersity after storage, likely associated with vesicle fusion events, which are thermodynamically favourable processes. Vesicles containing 14 mM sucrose exhibited a less pronounced size increase during storage.

The stabilizing effect of sucrose is attributed to its interaction with the lipid bilayer. During dehydration, sucrose solutions become supersaturated and may form a vitreous, amorphous solid matrix that physically separates vesicles, limits mobility, and increases the activation energy of fusion processes. After rehydration, sugars remain intercalated between phospholipids both below and above the gel-to- liquid crystalline transition temperature (Tc), reducing solute leakage and stabilizing membrane structure [4].

Together, these results demonstrate that sucrose concentration critically modulates vesicle size, encapsulation efficiency, and long-term stability of DPPC:Cholesterol DRVs encapsulating hrEGF-rP64k. The 40 mM condition preserves antigen loading, while 14 mM enhances storage stability despite reducing encapsulation efficiency.

This physicochemical characterization provides a foundation for considering liposomal DRVs as a biodegradable alternative platform for antigen delivery in anti-EGF immunotherapy.

References

1. Doorn EV (2016) Local reactions induced by oil-based vaccine adjuvants. Vaccine 34(42): 5095-5102.

2. Kirby C, Gregoriadis G (1984) Dehydration-Rehydration Vesicles: A Simple Method for High Yield Drug Entrapment in Liposomes. Bio/Technology 2: 979–984.

3. Lanio, ME, Luzardo MC, Alvarez C, Martinez Y, Calderon L et al. (2008) Humoral immune response against EGF encapsulated in DRVs. Journal of Liposome Research 18: 1-19.

4. Maitani Y, Aso Y, Yamada A, Yoshioka S (2008) Effect of sugars on storage stability of lyophilized liposomes. International Journal of Pharmaceutics 356: 69-75.

Figure 1: Size Of Liposomal Preparations in the Presence or Absence of Sucrose.

Figure 2: Encapsulation Efficiency of the Hregf-Rp64k Conjugate in Liposomes with or without Sucrose Stored in the Lyophilized State.

References

  1. Doorn EV (2016) Local reactions induced by oil-based vaccine adjuvants. Vaccine 34(42): 5095-5102.
  2. Kirby C, Gregoriadis G (1984) Dehydration-Rehydration Vesicles: A Simple Method for High Yield Drug Entrapment in Liposomes. Bio/Technology 2: 979–984.
  3. Lanio, ME, Luzardo MC, Alvarez C, Martinez Y, Calderon L et al. (2008) Humoral immune response against EGF encapsulated in DRVs. Journal of Liposome Research 18: 1-19.
  4. Maitani Y, Aso Y, Yamada A, Yoshioka S (2008) Effect of sugars on storage stability of lyophilized liposomes. International Journal of Pharmaceutics 356: 69-75.

PDF of this article

Related articles